Welcome to LookChem.com Sign In|Join Free
  • or
1-fluoro-3-(4-nitrophenoxy)benzene is an organic compound characterized by the presence of a fluorine atom at the 1st position, a nitro group at the 4th position of the phenoxy ring, and a benzene ring at the 3rd position. This molecule is a derivative of phenol, with a fluorobenzene group attached to the hydroxyl group of the phenol. The compound is known for its potential applications in the synthesis of pharmaceuticals and agrochemicals, as well as in materials science. It is important to note that due to the presence of the nitro group, 1-fluoro-3-(4-nitrophenoxy)benzene may be sensitive to heat and shock, and should be handled with care.

34859-79-5

Post Buying Request

34859-79-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

34859-79-5 Usage

Structure

A derivative of benzene with a fluorine atom and a 4-nitrophenoxy group attached to the benzene ring.

Usage

Commonly used in organic synthesis and pharmaceutical research.

Applications

Potential applications in the development of pharmaceutical drugs and agrochemicals.

Role

Used as an intermediate in the production of other organic compounds.

Safety

Important to handle with care, as it can be hazardous if not properly managed.

Check Digit Verification of cas no

The CAS Registry Mumber 34859-79-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,8,5 and 9 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 34859-79:
(7*3)+(6*4)+(5*8)+(4*5)+(3*9)+(2*7)+(1*9)=155
155 % 10 = 5
So 34859-79-5 is a valid CAS Registry Number.

34859-79-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-fluoro-3-(4-nitrophenoxy)-benzene

1.2 Other means of identification

Product number -
Other names 3'-Fluor-4-nitro-diphenylaether

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:34859-79-5 SDS

34859-79-5Downstream Products

34859-79-5Relevant academic research and scientific papers

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF EPILEPSY

-

Paragraph 0134; 0144, (2020/06/19)

The present invention provides a novel heterocyclic compound represented by Formula [I] and a salt thereof: wherein the symbols are as defined in the specification, which is useful for treating, preventing and/or diagnosing seizure and the like in disease involving epileptic seizure or convulsive seizure (including multiple drug resistant seizure, refractory seizure, acute symptomatic seizure, febrile seizure and status epilepticus), as well as a medical use therefor.

CsF/clinoptilolite: An efficient solid base in SNAr and copper-catalyzed Ullmann reactions

Keipour, Hoda,Hosseini, Abolfazl,Afsari, Amir,Oladee, Razieh,Khalilzadeh, Mohammad A.,Ollevier, Thierry

, p. 95 - 104 (2016/01/16)

CsF/clinoptilolite was found to be an efficient solid base catalyst for both SNAr and Ullmann ether reactions. A general and efficient one-step procedure was developed for the synthesis of biaryl ethers via direct coupling of electron-deficient aryl halides to phenols using CsF/clinoptilolite. The protocol was also applied to electron-rich aryl halides by addition of a catalytic amount of copper oxide nanoparticles. Both SNAr and Ullmann reactions were rapid and provided good to excellent yields.

A focused library of protein tyrosine phosphatase inhibitors

Comeau, Anthony B.,Critton, David A.,Page, Rebecca,Seto, Christopher T.

supporting information; experimental part, p. 6768 - 6772 (2010/11/18)

Protein tyrosine phosphatases such as PTP1B and YopH are potential targets for the development of therapeutic agents against a variety of pathological conditions including diabetes, obesity, and infection by the bacterium Yersinia pestis. A focused library of bidentate α-ketoacid-based inhibitors has been screened against several tyrosine phosphatases. Compound 2a has IC 50 values of 43 and 220 nM against YopH and PTP1B, respectively, and shows a 30-fold selectivity for PTP1B over the closely related phosphatase TCPTP.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 34859-79-5